Search

everythinglearnresearchcommunity

for

Search:↓

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Improving blood vessel health and controlling uric acid may help manage alopecia areata.

The cream effectively treats scalp psoriasis, improving symptoms and quality of life, with high patient satisfaction.

Bazi Bushen capsules reduce skin aging and damage from UV rays.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

SLE is likely one disease with various symptoms, not multiple distinct diseases.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

A fragment of human type XVII collagen shows great potential for skin health and wound healing.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

The IRE gene is important for normal root hair growth in Arabidopsis plants.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

Brown Adipose Tissue (BAT) could potentially treat Polycystic Ovary Syndrome (PCOS) by controlling energy balance and lipid homeostasis, but more human research is needed.

Early detection, prevention, and proper management can reduce TB-IRIS complications and deaths in HIV patients.

5-ARI therapy may help prevent prostate cancer progression.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.